Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency

Author(s):
Anker, S.D.; Schroeder, S.; Atar, D.; Bax, J.J.; Ceconi, C.; Cowie, M.R.; AdamCrisp; Dominjon, F.; Ford, I.; Ghofrani, H.A.; Gropper, S.; Hindricks, G.; Hlatky, M.A.; Holcomb, R.; Honarpour, N.; Jukema, J.W.; Kim, A.M.; Kunz, M.; Lefkowitz, M.; Floch, C. le; Landmesser, U.; McDonagh, T.A.; McMurray, J.J.; Merkely, B.; Packer, M.; Prasad, K.; Revkin, J.; Rosano, G.M.C.; Somaratne, R.; Stough, W.G.; Voors, A.A.; Ruschitzka, F.
Published
2016
Publication type
Article / Letter to editor
Heart failureClinical trialEndpoint determinationSurrogate endpoints
Date issued
2016-05-31
Language
English
Is part of
European Journal of Heart Failure (2016), Vol. 18, no. 5, p. 482-489
hdl
1887/114144
doi
10.1002/ejhf.516